Advertisement
Product › Details
Biofloat™ surface coatings for consumables in cell culture
Next higher product group | 3D cell culture technology_o | |
Status | 2020-05-28 sales start | |
Organisation | faCellitate (a venture of Chemovator GmbH) | |
Today | faCellitate GmbH | |
Group | BASF (Group) | |
Organisation 2 | BASF AG | |
Today | BASF S.E. | |
Group | BASF (Group) | |
Chemovator GmbH. (5/28/20). "Press Release: BASF Startup Incubator Celebrates Second Anniversary and faCellitate Product Launch". Mannheim.
> Venture Team faCellitate develops new ways for Life Science research with first product line BIOFLOAT™
> Interactive surface coatings for advanced cell technologies
> Chemovator now supports 11 Venture Teams with innovative ideas
Two years after the foundation of the Chemovator GmbH, the first Life Science Venture Team “faCellitate” is now ready to launch their first product line. BIOFLOAT™ are surface coatings for consumables in cell culture. The benefit: The cells can grow under conditions close to their natural environment, making laboratory results more reliable and reproducible than before. “In the long run, it is possible to increase predictability and efficiency of preclinical cell culture models, reduce animal studies and reduce the high costs for research, drug development, and toxicological studies.” reveals Dr. Véronique Schwartz, team leader and specialist in polymer chemistry. The new coatings enable the cultivation of cells for various areas of biomedical research such as toxicology, stem cell, cancer and drug research.
Imitation of natural cell environment
“Mammalian cells such as cancer, stem, or primary cells serve as basic research models when it comes to studying biological processes, disease patterns, and drug interactions. However, these cells are cultivated under conditions that do not reflect their natural environment well,” explains Schwartz. The limited reliability of cell culture models narrows the potential of biomedical research.
"Our mission is to change this by creating biologically relevant environments that our customers can use to imitate the way cells grow in the human body." This is achieved by providing a synthetic polymer coating layer on which the cell culture conditions are adjusted.
faCellitate-surface coatings are conveniently applied to consumables such as microtiter plates, laboratory containers, or cell culture bottles. The BIOFLOAT™ technology creates a highly defined and cell-repellent surface that adapts to the shape of the consumables. Inert polymers enable cells to grow in a three-dimensional space and form uniform multicellular spheroids. With traditional two-dimensional cell culture methods, cells can only spread on the flat surface of laboratory materials.
From laboratory to market readiness
The development of the new coatings started in BASF’s Advanced Materials & Systems research. In 2018 the scientists successfully applied with their promising idea to the newly founded BASF incubator “Chemovator” and turned into the first Venture Team with the name "faCellitate". Since then, Chemovator supports the team in developing a suitable business model.
"The protected space of Chemovator proved to be a great platform for commercial validation and getting in touch with potential customers. On top, it was possible to work with BASF-experts, such as our colleagues from the Toxicology and Materials Research, but also with our external collaboration partners, researchers from the Leibniz Institute for Polymer Research at the Max Bergmann Center for Biomaterials and experienced external entrepreneurs from the Chemovator network. They helped us to quickly develop our technology to market readiness," says Dr. Tobias Mentzel, Venture Team member and specialist in biotechnology and drug development.
Chemovator supports quick market development
The development continues: the researchers are already developing their second product line. “I am very proud that faCellitate is now taking this step. I am amazed at how quickly a research topic can get from laboratory to market. We were able to learn and develop a lot together with our first venture faCellitate. The Venture Team will soon move out of our incubator since the two year incubation period is over. Then we have more space for new innovative ideas.”, emphasizes Dr. Markus Bold, Managing Director of Chemovator GmbH.
Since the foundation in 2018, Chemovator has built a portfolio of 11 Venture Teams and supports them in turning their ideas into investable and scalable business opportunities.
About Chemovator GmbH
Chemovator is the business incubator of BASF – available for all BASF employees with innovative ideas around chemistry. Complementary to the existing innovation landscape of BASF, Chemovator offers a protected space to test new business ideas, products or innovative services and turn them into investable and scalable business models.
The wholly-owned subsidiary of BASF New Business GmbH was founded in 2018 and is located in Mannheim. Here, Chemovator offers an unconventional startup environment with plenty of space for creativity. From early validation to successful commercialization, all Venture Teams receive support from experienced entrepreneurs and investors, who have built startups and new businesses from scratch. Their support ranks from coaching over mentoring to providing extended network opportunities.
Further information at www.chemovator.com
For latest updates follow us on LinkedIn, Facebook, Instagram and Twitter.
If you want to become part of the exclusive Chemovator press distribution list, write an e-mail to lisa.schneider@chemovator.com
Contact Press and Media
Lisa Schneider
T +49 621 60 92350
E lisa.schneider@chemovator.com
Record changed: 2023-07-10 |
Advertisement
More documents for 3D cell culture technology_o
- [1] HeartBeat.bio AG. (11/02/23). "Press Release: HeartBeat.bio Raises € 4.5 Million in Pre-Series A Financing to Drive Development of Organoid Screening Platform for Cardiac Drug Discovery". Vienna....
- [2] faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim....
- [3] faCelliate GmbH. (10/11/22). "Press Release: faCellitate Starts Marketing New 384-well Spheroid Microplate". Mannheim....
- [4] HeartBeat.bio AG. (10/5/22). "Press Release: HeartBeat.bio Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna....
- [5] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
- [6] TreeFrog Therapeutics SAS. (2/5/20). "Press Release: TreeFrog Therapeutics Brings in Senior Profiles to Drive the Advent of High-quality and Affordable Allogenic Cell Therapies". Bordeaux....
- [7] TreeFrog Therapeutics SAS. (5/13/19). "Press Release: TreeFrog Therapeutics Raises over €7M ($7.8M) in Series A Financing Round 6 Months after Incorporation". Bordeaux....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top